Skip to main content

Featured

Canada’s Auto Industry Is Split on a U.S. Tariff Deal: What It Means for Your Wallet

  Canadian Money Brief • Tariffs & Trade • Saturday, November 14, 2026 Ottawa is once again trying to land a tariff deal with Washington. This time, the biggest fight may be inside Canada's own auto industry, and the outcome could reach your paycheque, your car purchase and your savings. Canada's auto manufacturers agree on the goal: get U.S. tariffs on Canadian-built vehicles down. They do not agree on how fast to move or what to accept. According to a Globe and Mail report published overnight, the Detroit Three (Ford, GM and Stellantis) want a deal sooner rather than later, even an imperfect one, while Honda and Toyota are pushing Ottawa toward a very different design. It matters now because of the clock. Canadian-built vehicles already face a 25% U.S. tariff on their non-American content, and Washington has threatened to double the headline rate to 50% on January 1, 2027. Honda has warned that doubling would be catastrophic for the North American industry. Prime Minister...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment